Sat-18-07-2020, 21:22 PM
In Cosentyx Lilly had set itself a low bar; cross-trial comparisons suggest that two rival anti-IL-23s, Abbvie’s Skyrizi and Johnson & Johnson’s Tremfya, would have been harder for mirikizumab to beat.
|
Mirikizumab Superior to Cosentyx in phase 3 psoriasis study
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-17-07-2020, 20:43 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by jiml - Fri-17-07-2020, 21:14 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by JohnB - Sat-18-07-2020, 20:54 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Sun-19-07-2020, 11:25 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Caroline - Fri-24-07-2020, 06:10 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-24-07-2020, 11:41 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Caroline - Fri-24-07-2020, 12:04 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-24-07-2020, 12:07 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by D Foster - Sat-18-07-2020, 21:22 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
|
ORKA-002 for psoriasis phase 1 started | Fred | 1 | 1,457 |
Tue-13-01-2026, 13:28 PM Last Post: Fred |
|
|
Vunakizumab Phase III for psoriasis | Fred | 1 | 553 |
Fri-02-01-2026, 20:33 PM Last Post: Caroline |
|
|
Zasocitinib phase 3 plaque psoriasis data | Fred | 0 | 557 |
Thu-18-12-2025, 13:57 PM Last Post: Fred |
|
|
si-544 Phase 1b trial in psoriasis | Fred | 4 | 1,980 |
Wed-22-10-2025, 20:27 PM Last Post: Fred |
|
|
ORKA-001 for psoriasis phase 2a | Fred | 0 | 1,342 |
Mon-21-07-2025, 12:35 PM Last Post: Fred |